Drug intelligence / Profile preview

acetaminophen + caffeine + chlorpheniramine

Development stage
Unknown
Lead developer
Biotech Laboratorios
Modality
Small Molecules
Administration
Oral
01

Overview

Acetaminophen + caffeine + chlorpheniramine is an over-the-counter (OTC) fixed-dose combination drug product used for the symptomatic relief of the common cold, flu, and allergic rhinitis. It combines three active ingredients with complementary mechanisms of action: acetaminophen (paracetamol), an analgesic and antipyretic that acts primarily by inhibiting prostaglandin synthesis in the central nervous system; caffeine, a central nervous system stimulant and adenosine receptor antagonist that enhances the analgesic efficacy of acetaminophen; and chlorpheniramine, a first-generation H1 histamine receptor antagonist (antihistamine) that provides antiallergic and anticholinergic effects to reduce runny nose, sneezing, and watery eyes. This combination is marketed under various brand names, such as Rinot by Biotech Laboratorios in Venezuela, and is widely used to treat symptoms like fever, headache, body aches, and nasal congestion.

Brand names
999 Cold Remedy999 Ganmaoling ColdAlivetAlivet 4DAlivet4DAlivet-4DAlivet DíaAlivet LimónAngrip DíaAscafyl PlusDolgripPanpyrin-TRinotRinot XSinutilSinutil AdultosSinutil Día
Other names
acetaminofén + cafeína + clorfeniraminaacetaminofén + cafeína + clorfeniramina maleatoacetaminophen + caffeine + chlorpheniramine maleateacetaminophen, caffeine, and chlorpheniramineacetaminophen, caffeine, and chlorpheniramine maleateparacetamol + cafeína + clorfenaminaparacetamol + cafeína + clorfeniraminaparacetamol + caffeine + chlorphenamineparacetamol + caffeine + chlorpheniramineparacetamol + caffeine + chlorpheniramine maleateparacetamol, caffeine, and chlorphenamineparacetamol, caffeine, and chlorpheniramineparacetamol, caffeine, and chlorpheniramine maleate
02

Targets

mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on acetaminophen + caffeine + chlorpheniramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + caffeine + chlorpheniramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call